ALYQ
- Product NDC
- 42291-804
- 11-digit product format
- 422910804
- Labeler code
- 42291
- Product ID
- 42291-804_ec193ea7-dc76-303f-e053-2a95a90abf47
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA209942
- Marketing category
- ANDA
- Marketing start
- 2019-02-18
- Marketing end
- 0000-00-00
- Substance
- TADALAFIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-804 | ALYQ (TADALAFIL) TABLET, FILM COATED [AVKARE] | 5 | Legacy NDC | 20240111_81f4efca-0ce1-d975-e053-2a91aa0ae8b4.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-804-60 | 42291080460 | 60 TABLET, FILM COATED in 1 BOTTLE (42291-804-60) | 2019-02-18 | 0000-00-00 | No | No | Current |